LEADER 01306nam  2200337Ia 450 
001 9910698826103321
005 20090528162407.0
035   $a(CKB)5470000002397607
035   $a(OCoLC)355961718
035   $a(EXLCZ)995470000002397607
100   $a20090528d2001      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for FDA reviewers$b[electronic resource] $epremarket notification submissions for transfer sets (excluding sterile connecting sets)
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,$d[2001]
215   $ai, 3 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on May 28, 2009).
300   $a"July 2001".
517   $aGuidance for FDA reviewers 
606   $aMedical instruments and apparatus$xEvaluation$xGovernment policy$zUnited States
615  0$aMedical instruments and apparatus$xEvaluation$xGovernment policy
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698826103321
996   $aGuidance for FDA reviewers$93467137
997   $aUNINA